HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use METOPROLOL TARTRATE INJECTION safely and effectively. See full prescribing information for METOPROLOL TARTRATE INJECTION. METOPROLOL TARTRATE Injection, for intravenous use Initial U.S. Approval: 1978 INDICATIONS AND USAGEMetoprolol tartrate is a beta-adrenergic receptor inhibitor indicated for the treatment of definite or suspected acute myocardial infarction in hemodynamically stable patients to reduce cardiovascular mortality when used in conjunction with oral metoprolol maintenance therapy. (1) DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHSInjection: 5 mg metoprolol tartrate supplied in 5 mL ampules. (3) CONTRAINDICATIONSWARNINGS AND PRECAUTIONSADVERSE REACTIONS
To report SUSPECTED ADVERSE REACTIONS, contact Hospira, Inc. at 1-800-441-4100, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONS
USE IN SPECIFIC POPULATIONS
See 17 for PATIENT COUNSELING INFORMATION. Revised: 12/2020 |

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
metoprolol tartrate injection, USP - CARPUJECT
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
metoprolol tartrate injection, USP - CARPUJECT Quick Finder
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.